Case Report: Tumor Microenvironment Characteristics in a Patient With HER2 Mutant Lung Squamous Cell Carcinoma Harboring High PD-L1 Expression Who Presented Hyperprogressive Disease

BACKGROUND: High PD-L1 expression in non-small cell lung cancer (NSCLC) is evident to predict elevated immunotherapy efficacy, to which NSCLC with onco-driver gene mutations is probed with poor responsiveness. Thus, it is of great interest to investigate how effective immune monotherapy is in the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Lixia, Yu, Yinghui, Lan, Fen, Yan, Junrong, Li, Jinfan, Li, Wen, Xia, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739789/
https://www.ncbi.nlm.nih.gov/pubmed/35004282
http://dx.doi.org/10.3389/fonc.2021.760703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739789/
https://www.ncbi.nlm.nih.gov/pubmed/35004282
http://dx.doi.org/10.3389/fonc.2021.760703

Ejemplares similares